Immunovant, Inc. 4 Filing

Ticker: IMVT · Form: 4 · Filed: Apr 9, 2026 · CIK: 0001764013

Immunovant, Inc. 4 Filing Summary
FieldDetail
CompanyImmunovant, Inc. (IMVT)
Form Type4
Filed DateApr 9, 2026
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 4 filing submitted by Immunovant, Inc. (ticker: IMVT) to the SEC on Apr 9, 2026.

Where can I view the full 4 filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Details

This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 9, 2026 regarding Immunovant, Inc. (IMVT). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.

View full filing on EDGAR

View Full Filing

View this 4 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.